ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

NCI’s Independence To Be Challenged By Edwards When Cancer Act Comes Up For Renewal Next Year

December 21, 1973

Niass General’s Sanders Reported offered Asst. Secretary Job

February 18, 1977

Copeland Named Director, UF Cancer Center

February 10, 1995

Environmental Carcinogenesis Gets 17% Of NCI Budget

February 20, 1976

Without Advance Directives, Families Prolong Treatment

April 27, 2001

NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens

March 19, 1999